Predictors of discontinuation of osteoporosis treatment: sub-analysis of the Japanese osteoporosis intervention trial-05 (JOINT-05)
Journal of Bone and Mineral Metabolism · 2024
DOI: 10.1007/s00774-024-01541-3 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of Bone and Mineral Metabolism, 2024. Verfasst von Yasuhiro Takeuchi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Toranomon Hospital Endocrine Center, 2-2-2 Toranomon, Minato-ku, Tokyo, 105-8470, Japan. takeuchi-tky@toranomon.gr.jp. Hauptthemen laut MEDLINE: Alendronate. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Public Health Research Foundation, Asahi Kasei Pharma Corporation.
Abstract (Originalsprache)
Introduction
To identify predictors of discontinuing treatment with teriparatide (TPTD) and alendronate (ALN), data from a randomized, controlled trial (JOINT-05) involving postmenopausal Japanese women at high risk of fracture were re-analyzed. Materials and Methods Participants received sequential therapy with once-weekly TPTD for 72 weeks followed by ALN for 48 weeks (TPTD-ALN group) or monotherapy with ALN for 120 weeks (ALN group). Background data including comorbidities, fracture prevalence, cognitive function, quality of life, activities of daily living, bone metabolism parameters, and nutrient intake were collected. The endpoints were 3 types of discontinuations by the reason: a poor compliance, adverse events (AEs), or any reason including those unrelated to AEs or poor compliance. Odds ratios (ORs) of baseline predictors of discontinuation were evaluated by single or multiple regression analysis.
Results
A total of 234 (49.0%) patients in the TPTD-ALN group and 167 (34.2%) patients in the ALN group discontinued. In the TPTD-ALN group, a lower serum calcium level was a significant predictor of compliance-related discontinuation. Serum 25-hydroxyvitamin D levels were lower in patients with lower serum calcium levels than with higher serum calcium levels. In the ALN group, poor cognitive function was significantly associated with compliance-related discontinuation, and higher body mass index and alcohol intake were predictors of AE-related discontinuation. Predictors of discontinuation were drug-specific. Lower serum calcium levels and poor cognitive function were predictors of discontinuing once-weekly TPTD and ALN, respectively.
Conclusion
When starting TPTD and ALN treatment, careful attention to patients with lower serum calcium levels and poor cognitive function, respectively, may be needed for better treatment continuity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Toranomon Hospital Endocrine Center, 2-2-2 Toranomon, Minato-ku, Tokyo, 105-8470, Japan. takeuchi-tky@toranomon.gr.jp.
- Okinaka Memorial Institute for Medical Research, Minato-ku, Tokyo, Japan. takeuchi-tky@toranomon.gr.jp.
- Department of Clinical Biostatistics, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
- Public Health Research Foundation, Shinjuku-ku, Tokyo, Japan.
- Department of Rehabilitation, Sanin Rosai Hospital, Yonago, Tottori, Japan.
- Seirei Hamamatsu General Hospital, Hamamatsu, Shizuoka, Japan.
Förderung
- Public Health Research Foundation
- Asahi Kasei Pharma Corporation
Zitieren
APA
Takeuchi, Y., Nakatsuka, Y., Tanaka, S., Kuroda, T., Hagino, H., Mori, S., & Soen, S. (2024). Predictors of discontinuation of osteoporosis treatment: sub-analysis of the Japanese osteoporosis intervention trial-05 (JOINT-05). Journal of Bone and Mineral Metabolism. https://doi.org/10.1007/s00774-024-01541-3
Vancouver
Takeuchi Y, Nakatsuka Y, Tanaka S, Kuroda T, Hagino H, Mori S, et al. Predictors of discontinuation of osteoporosis treatment: sub-analysis of the Japanese osteoporosis intervention trial-05 (JOINT-05). Journal of Bone and Mineral Metabolism. 2024. doi:10.1007/s00774-024-01541-3
BibTeX
@article{Takeuchi2024,
author = {Takeuchi, Yasuhiro and Nakatsuka, Yuki and Tanaka, Shiro and Kuroda, Tatsuhiko and Hagino, Hiroshi and Mori, Satoshi and Soen, Satoshi},
title = {Predictors of discontinuation of osteoporosis treatment: sub-analysis of the Japanese osteoporosis intervention trial-05 (JOINT-05)},
journal = {Journal of Bone and Mineral Metabolism},
year = {2024},
doi = {10.1007/s00774-024-01541-3}
}
EUVIMED